Cargando…

Arterial stiffness as a risk factor for cardiovascular events and all‐cause mortality in people with Type 2 diabetes

AIM: To quantify the risk of different non‐invasive arterial stiffness measurements with macrovascular disease and all‐cause mortality in high‐risk people with Type 2 diabetes. METHODS: We conducted a prospective cohort study of 1910 people with Type 2 diabetes included in the Second Manifestations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharif, S., Visseren, F. L. J., Spiering, W., de Jong, P. A., Bots, M. L., Westerink, J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767543/ https://www.ncbi.nlm.nih.gov/pubmed/30920676 http://dx.doi.org/10.1111/dme.13954

Ejemplares similares

Low-grade inflammation as a risk factor for cardiovascular events and all-cause mortality in patients with type 2 diabetes
por: Sharif, Shahnam, et al.
Publicado: (2021)

Mediation analysis of the relationship between type 2 diabetes and cardiovascular events and all‐cause mortality: Findings from the SMART cohort
por: Sharif, Shahnam, et al.
Publicado: (2019)

The relation between urinary sodium and potassium excretion and risk of cardiovascular events and mortality in patients with cardiovascular disease
por: Groenland, Eline H., et al.
Publicado: (2022)

The influence of baseline risk on the relation between HbA1c and risk for new cardiovascular events and mortality in patients with type 2 diabetes and symptomatic cardiovascular disease
por: Bots, Sophie H., et al.
Publicado: (2016)

Relationship between classic vascular risk factors and cumulative recurrent cardiovascular event burden in patients with clinically manifest vascular disease: results from the UCC-SMART prospective cohort study
por: de Vries, Tamar Irene, et al.
Publicado: (2021)

Physical exercise volume, type, and intensity and risk of all-cause mortality and cardiovascular events in patients with cardiovascular disease: a mediation analysis
por: Bonekamp, Nadia E, et al.
Publicado: (2023)

Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
por: van Kleef, Monique E. A. M., et al.
Publicado: (2020)

Association between ankle-brachial blood pressure index with all-cause and cardiovascular mortality in adults without arterial stiffness
por: Meng, Zhe, et al.
Publicado: (2023)

Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill
por: Lafeber, M., et al.
Publicado: (2016)

Association of arterial stiffness with all-cause and cause-specific mortality in the diabetic population: A national cohort study
por: Liu, Cun, et al.
Publicado: (2023)

Added value of cardiovascular calcifications for prediction of recurrent cardiovascular events and cardiovascular interventions in patients with established cardiovascular disease
por: van ’t Klooster, Cilie C., et al.
Publicado: (2021)

Impact of Arterial Stiffness on All-Cause Mortality in Patients Hospitalized With COVID-19 in Spain
por: Rodilla, Enrique, et al.
Publicado: (2020)

All-Cause Mortality and Serious Cardiovascular Events in People with Hip and Knee Osteoarthritis: A Population Based Cohort Study
por: Hawker, Gillian A., et al.
Publicado: (2014)

Screen-detected abnormal ankle brachial index: A risk indicator for future cardiovascular morbidity and mortality in patients with manifest cardiovascular disease
por: Jagt, Vivianne L., et al.
Publicado: (2022)

Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care
por: de Beus, Esther, et al.
Publicado: (2017)

Serum IL8 is not associated with cardiovascular events but with all-cause mortality
por: Moreno Velásquez, Ilais, et al.
Publicado: (2019)

Association of social relationships with incident cardiovascular events and all-cause mortality
por: Gronewold, Janine, et al.
Publicado: (2020)

Association between egg consumption and cardiovascular disease events, diabetes and all-cause mortality
por: Guo, Jing, et al.
Publicado: (2017)

Associations of polyneuropathy with risk of all‐cause and cardiovascular mortality, cardiovascular disease events stratified by diabetes status
por: Kim, Kyuho, et al.
Publicado: (2023)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
por: Mehrabani-Zeinabad, Kamran, et al.
Publicado: (2023)

Trajectories of physical health-related quality of life and the risk of incident cardiovascular disease events and all-cause mortality in older people()
por: Phyo, Aung Zaw Zaw, et al.
Publicado: (2022)

Major adverse cardiovascular events and all-cause mortality after emergency general surgery among kidney failure patients
por: Anderson, Benjamin, et al.
Publicado: (2022)

Triglyceride-glucose (TyG) index is a predictor of arterial stiffness, incidence of diabetes, cardiovascular disease, and all-cause and cardiovascular mortality: A longitudinal two-cohort analysis
por: Muhammad, Iram Faqir, et al.
Publicado: (2023)

Mitochondrial DNA copy number is associated with all‐cause mortality and cardiovascular events in patients with peripheral arterial disease
por: Koller, A., et al.
Publicado: (2020)

Peripheral artery disease and all-cause and cardiovascular mortality in patients with NAFLD
por: Ciardullo, S., et al.
Publicado: (2022)

Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients
por: Pihlstrøm, Hege, et al.
Publicado: (2014)

Predictive Value of Cumulative Blood Pressure for All-Cause Mortality and Cardiovascular Events
por: Wang, Yan Xiu, et al.
Publicado: (2017)

Prediction model for cardiovascular events or all-cause mortality in incident dialysis patients
por: Inaguma, Daijo, et al.
Publicado: (2019)

Liver stiffness (Fibroscan®) is a predictor of all‐cause mortality in people with non‐alcoholic fatty liver disease
por: Braude, Michael, et al.
Publicado: (2022)

Influence of Statin Therapy on the Incidence of Cardiovascular Events, Cancer, and All-Cause Mortality in People Living With HIV: A Meta-Analysis
por: Li, Yanping, et al.
Publicado: (2021)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies
por: Kramer, Caroline K., et al.
Publicado: (2011)

Sodium and potassium intake and risk of cardiovascular events and all-cause mortality: the Rotterdam Study
por: Geleijnse, Johanna M., et al.
Publicado: (2007)

Sodium-based paracetamol: impact on blood pressure, cardiovascular events, and all-cause mortality
por: Rao, Shishir, et al.
Publicado: (2023)

All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease
por: Salinero-Fort, MA, et al.
Publicado: (2022)

Oral health and all-cause, cardiovascular disease, and respiratory mortality in older people in the UK and USA
por: Kotronia, Eftychia, et al.
Publicado: (2021)

Systematic review and meta-analysis examining the relationship between postprandial hypotension, cardiovascular events, and all-cause mortality
por: Jenkins, David J A, et al.
Publicado: (2022)

Relationship of Arterial Stiffness Index and Pulse Pressure With Cardiovascular Disease and Mortality
por: Said, M. Abdullah, et al.
Publicado: (2018)

Urinary Proteomic Profile of Arterial Stiffness Is Associated With Mortality and Cardiovascular Outcomes
por: Wei, Dongmei, et al.
Publicado: (2022)

NT-proBNP for risk prediction of cardiovascular events and all-cause mortality: The getABI-study
por: Rudolf, Henrik, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ao6rc4vs50gb85b88cls4b1vck